Quick Answer
Bioquest Corp reported Cash And Cash Equivalents At Carrying Value of $33.5 thousand for the year ending 2022.
- Bioquest Corp showed an increase of +12,800.0% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
- This data is from Bioquest Corp's annual report (Form 10-K), filed with the SEC on August 15, 2022.
- XBRL data for this metric is available from 2012 to 2022 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $0.00 | Q3 2012: $14.4 thousand | Q4 2012: $12.5 thousand | Q1 2013: $10.2 thousand | Q2 2013: $8.0 thousand | Q3 2013: $3.1 thousand | Q4 2013: $4.00 | Q1 2014: $452.00 | Q2 2014: $543.9 thousand | Q3 2014: $848.0 thousand | Q4 2014: $401.2 thousand | Q1 2015: $310.9 thousand | Q4 2020: $70.00 | Q1 2021: $60.00 | Q3 2021: $2.7 thousand | Q4 2021: $818.00 | Q1 2022: $116.00 | Q2 2022: $33.5 thousand | Q3 2022: $15.0 thousand.
- Over the full 6 years of available data (2012 to 2022), Bioquest Corp's Cash And Cash Equivalents At Carrying Value has grown by 3,445.5%.
- Historical annual values: Fiscal year 2022: $33.5 thousand | Fiscal year 2021: $260.00 | Fiscal year 2020: $166.00 | Fiscal year 2014: $543.9 thousand | Fiscal year 2013: $8.0 thousand | Fiscal year 2012: $946.00.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: